Estimates are that pioneering CRISPR patents will be worth hundreds of millions of dollars for patent owners. At this event, Dr. Tara Nealey of Polsinelli Law will discuss notable patent disputes, the uncertainties in the overall CRISPR patent landscape, the positioning of the surrogate companies of the battling parties, and what it means for researchers. Refreshments will be provided.

Who: Tara Nealey, Ph.D., Polsinelli Law, St. Louis, Missouri

What: State of Innovation speaker series, Policy and Ethics portion

When: Wednesday, October 18 at 3 PM

Where: Colorado State University LSC Cherokee Park Ballroom